GENESIS(R) II CRUCIATE RETAINING ARTICULAR INSERT, TRIAL, SIZE 3-4, A/P 48 MM, M/L 68 MM, QTY 1, ...

FDA Device Recall #Z-1996-2013 — Class II — July 8, 2013

Recall Summary

Recall Number Z-1996-2013
Classification Class II — Moderate risk
Date Initiated July 8, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Smith & Nephew Inc
Location Memphis, TN
Product Type Devices
Quantity 9 units

Product Description

GENESIS(R) II CRUCIATE RETAINING ARTICULAR INSERT, TRIAL, SIZE 3-4, A/P 48 MM, M/L 68 MM, QTY 1, NON-STERILE, REF 71430490, Product Usage: Orthopedic

Reason for Recall

The products were produced using the wrong color material, resulting in the devices being red (used for deep dished inserts) instead of blue (used for cruciate retaining inserts).

Distribution Pattern

International only: Germany, France, United Arab Emirates, and United Kingdom.

Lot / Code Information

Lot Number 12LM03798

Other Recalls from Smith & Nephew Inc

Recall # Classification Product Date
Z-0282-2025 Class II smith&nephew LEGION OXINIUM POSTERIOR STABILIZE... Oct 2, 2024
Z-0281-2025 Class II smith&nephew GENESIS II NONPOROUS POSTERIOR STA... Oct 2, 2024
Z-0277-2025 Class II smith&nephew LEIGON OXINIUM CONSTRAINED NONPORO... Oct 2, 2024
Z-0278-2025 Class II smith&nephew LEIGON OXINIUM CONSTRAINED NONPORO... Oct 2, 2024
Z-1901-2024 Class II smith&nephew OXINIUM Femoral Head 12/14 Taper, ... Apr 24, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.